50 Years of Topical Retinoids for Acne: Evolution of Treatment
- PMID: 33871811
- DOI: 10.1007/s40257-021-00594-8
50 Years of Topical Retinoids for Acne: Evolution of Treatment
Abstract
Since the US Food and Drug Administration (FDA) approved tretinoin in 1971, retinoids alone or combined with other agents have become the mainstay of acne treatment. Retinoids act through binding to retinoic acid receptors, altering expression levels of hundreds of cellular proteins affecting multiple pathways involved in acne pathogenesis. Retinoids have evolved from first-generation agents, such as tretinoin, through chemical modifications resulting in a second generation (etretinate and acitretin for psoriasis), a third generation (adapalene and tazarotene) and, most recently, a fourth (trifarotene). For all topical retinoids, local irritation has been associated with poor tolerability and suboptimal adherence. Efforts to improve tolerability have utilized novel delivery systems and/or novel agents. This qualitative literature review summarizes the evolution of the four topical single-agent retinoids available for the treatment of acne in the US today and their various formulations, presenting the rationale behind their development and data from key studies.
Similar articles
-
Topical Retinoids in Acne Vulgaris: A Systematic Review.Am J Clin Dermatol. 2019 Jun;20(3):345-365. doi: 10.1007/s40257-019-00423-z. Am J Clin Dermatol. 2019. PMID: 30674002
-
Tolerability of Topical Retinoids: Are There Clinically Meaningful Differences Among Topical Retinoids?J Cutan Med Surg. 2015 Nov-Dec;19(6):530-8. doi: 10.1177/1203475415591117. Epub 2015 Jun 18. J Cutan Med Surg. 2015. PMID: 26088502 Review.
-
Topical retinoids in acne--an evidence-based overview.J Dtsch Dermatol Ges. 2008 Dec;6(12):1023-31. doi: 10.1111/j.1610-0387.2008.06741.x. Epub 2008 May 13. J Dtsch Dermatol Ges. 2008. PMID: 18479477 Review. English, German.
-
Trifarotene (Aklief) - a new topical retinoid for acne.Med Lett Drugs Ther. 2019 Dec 16;61(1587):195-197. Med Lett Drugs Ther. 2019. PMID: 31999666 No abstract available.
-
A Novel Topical Retinoid for Acne: Trifarotene 50 μg/g Cream.Skin Therapy Lett. 2020 Mar;25(2):1-2. Skin Therapy Lett. 2020. PMID: 32196146
Cited by
-
The role of current synthetic and possible plant and marine phytochemical compounds in the treatment of acne.RSC Adv. 2024 Aug 5;14(33):24287-24321. doi: 10.1039/d4ra03865g. eCollection 2024 Jul 26. RSC Adv. 2024. PMID: 39104563 Free PMC article. Review.
-
All-trans retinoic acid pretreatment of mesenchymal stem cells enhances the therapeutic effect on acute kidney injury.Cell Commun Signal. 2024 May 27;22(1):291. doi: 10.1186/s12964-024-01671-1. Cell Commun Signal. 2024. PMID: 38802835 Free PMC article.
-
Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies.Int J Mol Sci. 2024 May 13;25(10):5302. doi: 10.3390/ijms25105302. Int J Mol Sci. 2024. PMID: 38791344 Free PMC article. Review.
-
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis.Dermatol Ther (Heidelb). 2024 May;14(5):1211-1227. doi: 10.1007/s13555-024-01155-7. Epub 2024 May 9. Dermatol Ther (Heidelb). 2024. PMID: 38724841 Free PMC article.
-
Liposomes and Other Nanocarriers for the Treatment of Acne Vulgaris: Improved Therapeutic Efficacy and Skin Tolerability.Pharmaceutics. 2024 Feb 22;16(3):309. doi: 10.3390/pharmaceutics16030309. Pharmaceutics. 2024. PMID: 38543203 Free PMC article. Review.
References
-
- US Food and Drug Administration. Drugs@FDA-Approved Drugs. 2020. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview... . Accessed 28 Apr 2020.
-
- Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl 1):1–29. - PubMed
-
- Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1–50. - PubMed
-
- Zaenglein AL, Pathy AL, Schlosser BJ, Alikhan A, Baldwin HE, Berson DS, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74(5):945–73 e33.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical